The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
Management of Graves’ Ophthalmopathy: Reality and Perspectives*
Open accessAbstract
Graves’ ophthalmopathy is an debilitating disease impairing the quality of life of affected individuals. Despite recent progress in the understanding of its pathogenesis, treatment is often not satisfactory. In mild cases, local therapeutic measures (artificial tears and ointments, sunglasses, nocturnal taping of the eyes, prisms) can control symptoms and signs. In severe forms of the disease (3–5%), aggressive measures are required. If the disease is active, high-dose glucocorticoids and/or orbital radiotherapy, or orbital decompression represent the mainstay of treatment. If the disease is severe but inactive, orbital decompression is preferred. Novel treatments such as somatostatin analogs or intravenous immunoglobulins are under evaluation. Rehabilitative (extraocular muscle or eyelid) surgery is often needed after treatment and inactivation of eye disease. Correction of both hyper- and hypothyroidism is crucial for the ophthalmopathy. Antithyroid drugs and thyroidectomy do not influence the course of the ophthalmopathy, whereas radioiodine treatment may cause the progression of preexisting ophthalmopathy, especially in smokers. The exacerbation, however, is prevented by glucocorticoids. In addition, thyroid ablation may prove beneficial for the ophthalmopathy in view of the pathogenetic model relating eye disease to autoimmune reactions directed against antigens shared by the thyroid and the orbit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Oei, H. Y., van Hagen, M., Postema, P. T. E., de Jong, M., Reubi, J. C., et al. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00181765 · Cited by 1,564
Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy
Mourits, M. P., Prummel, M. F., Wiersinga, W. M., & Koornneef, L. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2331047.x · Cited by 1,001
Solomon, S. (1969) · The Lancet · doi:10.1016/s0140-6736(69)92136-9 · Cited by 844
Mourits, M. P., Koornneef, L., Wiersinga, W. M., Prummel, M. F., Berghout, A., & van der Gaag, R. (1989) · British Journal of Ophthalmology · doi:10.1136/bjo.73.8.639 · Cited by 721
Relation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy
Bartalena, L., Marcocci, C., Bogazzi, F., Manetti, L., Tanda, M. L., Dell'Unto, E., Bruno-Bossio, G., Nardi, M., Bartolomei, M. P., Lepri, A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380201 · Cited by 715
Self-citationPathogenesis of Graves' Ophthalmopathy
Epstein, F. H., Bahn, R. S., & Heufelder, A. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292007 · Cited by 605
Graves' Ophthalmopathy: Current Concepts Regarding Pathogenesis and Management*
BURCH, H. B., & WARTOFSKY, L. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-6-747 · Cited by 598
Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism
Tallstedt, L., Lundell, G., Tørring, O., Wallin, G., Ljunggren, J.-G., Blomgren, H., & Taube, A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262603 · Cited by 521
Smoking and Risk of Graves' Disease
Prummel, M. F. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500040045034 · Cited by 503
Clinical Features of Graves' Ophthalmopathy in an Incidence Cohort
BARTLEY, G. B., FATOURECHI, V., KADRMAS, E. F., JACOBSEN, S. J., ILSTRUP, D. M., GARRITY, J. A., & GORMAN, C. A. (1996) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70276-4 · Cited by 459
Bartley, G. B. (1994) · PubMed · Cited by 363
Prednisone and Cyclosporine in the Treatment of Severe Graves' Ophthalmopathy
Prummel, M. F., Mourits, M. P., Berghout, A., Krenning, E. P., van der Gaag, R., Koornneef, L., & Wiersinga, W. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911163212002 · Cited by 359
Shreeniwas, R., Koga, S., Karakurum, M., Pinsky, D., Kaiser, E., Brett, J., Wolitzky, B. A., Norton, C., Plocinski, J., & Benjamin, W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116122 · Cited by 334
Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy
Prummel, M. F., Berghout, A., Wiersinga, W. M., Mourits, M. P., Koornneef, L., & Blank, L. (1993) · The Lancet · doi:10.1016/0140-6736(93)92001-a · Cited by 332
Bartalena, L., Marcocci, C., Bogazzi, F., Panicucci, M., Lepri, A., & Pinchera, A. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911163212001 · Cited by 318
Self-citationCigarette Smoking and Treatment Outcomes in Graves Ophthalmopathy
Bartalena, L., Marcocci, C., Tanda, M. L., Manetti, L., Dell'Unto, E., Bartolomei, M. P., Nardi, M., Martino, E., & Pinchera, A. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-8-199810150-00010 · Cited by 295
Self-citationMILK ANTIBODIES AND MYOCARDIAL INFARCTION
DAVIES, D. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91520-7 · Cited by 294
VITTI, P., RAGO, T., CHIOVATO, L., PALLINI, S., SANTINI, F., FIORE, E., ROCCHI, R., MARTINO, E., & PINCHERA, A. (1997) · Thyroid · doi:10.1089/thy.1997.7.369 · Cited by 293
Self-citationExpression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue
Feliciello, A., Ciullo, I., Fenzi, G. F., Bonavolontà, G., Porcellini, A., & Avvedimento, E. V. (1993) · The Lancet · doi:10.1016/0140-6736(93)91475-2 · Cited by 288
Perros, P., Crombie, A. L., Matthews, J. N. S., & Kendall‐Taylor, P. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00516.x · Cited by 288
Bartalena, L., Marcocci, C., Chiovato, L., Laddaga, M., Lepri, G., Andreani, D., Cavallacci, G., Baschieri, L., & Pinchera, A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-6-1139 · Cited by 272
Self-citationCurrent Trends in the Management of Graves' Disease*
SOLOMON, B., GLINOER, D., LAGASSE, R., & WARTOFSKY, L. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1518 · Cited by 266
Supervoltage Orbital Radiotherapy for Graves' Ophthalmopathy1
DONALDSON, S. S., BAGSHAW, M. A., & KRISS, J. P. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-2-276 · Cited by 251
Effect of Abnormal Thyroid Function on the Severity of Graves' Ophthalmopathy
Prummel, M. F. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390170124027 · Cited by 238
The Initial Clinical Characteristics of Graves' Orbitopathy Vary With Age and Sex
Kendler, D. L. (1993) · Archives of Ophthalmology · doi:10.1001/archopht.1993.01090020051022 · Cited by 235
RANKIN, E. C. C., CHOY, E. H. S., KASSIMOS, D., KINGSLEY, G. H., SOPWTTH, A. M., ISENBERG, D. A., & PANAYI, G. S. (1995) · Rheumatology · doi:10.1093/rheumatology/34.4.334 · Cited by 231
Bahn, R. S., Dutton, C. M., Natt, N., Joba, W., Spitzweg, C., & Heufelder, A. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4676 · Cited by 228
Pfeilschifter, J., & Ziegler, R. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.8220832.x · Cited by 227 · cited 4×
“Recently, Pfeilschifter and Ziegler (256) prospectively followed 253 patients with a recent onset of Graves’ hyperthyroidism and found that cigarette smoking was associated with a 1.3-fold increased incidence of clinically relevant GO and with 2.6-fold and 3.1-fold increases in the incidence of proptosis and diplopia,…”
BackgroundInfluentialNatural history of thyroid associated ophthalmopathy
Perros, P., Cromble, A. L., & Kendall‐Taylor, P. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02597.x · Cited by 219
GERDING, M. N., TERWEE, C. B., DEKKER, F. W., KOORNNEEF, L., PRUMMEL, M. F., & WIERSINGA, W. M. (1997) · Thyroid · doi:10.1089/thy.1997.7.885 · Cited by 217
Hashizume, K., Ichikawa, K., Sakurai, A., Suzuki, S., Takeda, T., Kobayashi, M., Miyamoto, T., Arai, M., & Nagasawa, T. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104043241403 · Cited by 216
Costagliola, S., Rodien, P., Many, M. C., Ludgate, M., & Vassart, G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1458 · Cited by 208
Day, G. (1952) · The Lancet · doi:10.1016/s0140-6736(52)91316-0 · Cited by 202
Graves’ ophthalmopathy in relation to cigarette smoking and ethnic origin
Tellez, M., Cooper, J., & Edmonds, C. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb01445.x · Cited by 202
KAHALY, G., SCHREZENMEIR, J., KRAUSE, U., SCHWEIKERT, B., MEUER, S., MULLER, W., DENNERAUM, R., & BEYER, J. (1986) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1986.tb01016.x · Cited by 202
Bahn, R. S. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.998 · Cited by 200
More on smoking habits and Graves’ ophthalmopathy
Bartalena, L., Martino, E., Marcocci, C., Bogazzi, F., Panicucci, M., Velluzzi, F., Loviselli, A., & Pinchera, A. (1989) · Journal of Endocrinological Investigation · doi:10.1007/bf03350047 · Cited by 199
Self-citationImmunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy.
Weetman, A. P., Cohen, S. B., Gatter, K. C., Fells, P., & Shine, B. S. F. (1989) · PubMed Central · Cited by 188
Postpartum thyroid dysfunction in Mid Glamorgan
Fung, H. Y. M., Kologlu, M., Collison, K., John, R., Richards, C. J., Hall, R., & McGregor, A. M. (1988) · BMJ · doi:10.1136/bmj.296.6617.241 · Cited by 183
Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture
Sorisky, A. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.9.3428 · Cited by 179
A LONG‐TERM FOLLOW‐UP OF POSTPARTUM THYROIDITIS
OTHMAN, S., PHILLIPS, D. I. W., PARKES, A. B., RICHARDS, C. J., HARRIS, B., FUNG, H., DARKE, C., JOHN, R., HALL, R., & LAZARUS, J. H. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00898.x · Cited by 179
Studies on the occurrence of ophthalmopathy in Graves' disease
Marcocci, C., Bartalena, L., Bogazzi, F., Panicucci, M., & Pinchera, A. (1989) · Acta Endocrinologica · doi:10.1530/acta.0.1200473 · Cited by 172
Self-citationValyasevi, R. W., Erickson, D. Z., Harteneck, D. A., Dutton, C. M., Heufelder, A. E., Jyonouchi, S. C., & Bahn, R. S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.7.5838 · Cited by 172
Tallstedt, L., Lundell, G., Blomgren, H., & Bring, J. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300494 · Cited by 171
Surgical treatment of graves' disease: Subtotal or total thyroidectomy?
Miccoli, P., Vitti, P., Rago, T., Iacconi, P., Bartalena, L., Bogazzi, F., Fiore, E., Valeriano, R., Chiovato, L., Rocchi, R., et al. (1996) · Surgery · doi:10.1016/s0039-6060(96)80049-3 · Cited by 171
Self-citationde Carli, M. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.5.1120 · Cited by 171
HEUFELDER, A. E., DUTTON, C. M., SARKAR, G., DONOVAN, K. A., & BAHN, R. S. (1993) · Thyroid · doi:10.1089/thy.1993.3.297 · Cited by 169
Thyroid autoantibodies in thyroid cancer: Incidence and relationship with tumour outcome
Pacini, F., Mariotti, S., Formica, N., Elisei, R., Anelli, S., Capotorti, E., & Pinchera, A. (1988) · Acta Endocrinologica · doi:10.1530/acta.0.1190373 · Cited by 166
Self-citationAssociation between Graves' ophthalmopathy and smoking
BALAZS, C. (1990) · The Lancet · doi:10.1016/0140-6736(90)92251-c · Cited by 163
Classification of Eye Changes of Graves' Disease
(1992) · Thyroid · doi:10.1089/thy.1992.2.235 · Cited by 162
Cigarette Smoking and the Thyroid
BERTELSEN, J. B., & HEGEDÜS, L. (1994) · Thyroid · doi:10.1089/thy.1994.4.327 · Cited by 161
Marcocci, C., Bartalena, L., Bogazzi, F., Bruno-Bossio, G., Lepri, A., & Pinchera, A. (1991) · Journal of Endocrinological Investigation · doi:10.1007/bf03347943 · Cited by 153
Self-citationHeufelder, A. E., & Bahn, R. S. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00712.x · Cited by 149
Grubeck‐Loebenstein, B., Trieb, K., Sztankay, A., Holter, W., Anderl, H., & Wick, G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117289 · Cited by 147
Is endocrine ophthalmopathy related to smoking?
Hägg, E., & Asplund, K. (1987) · BMJ · doi:10.1136/bmj.295.6599.634 · Cited by 146
Low- Versus High-Dose Radiotherapy for Graves’ Ophthalmopathy: A Randomized, Single Blind Trial
Kahaly, G. J., Rösler, H.-P., Pitz, S., & Hommel, G. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6257 · Cited by 144
Kung, A. W. C., Yau, C., & Cheng, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.2.7913934 · Cited by 139
Treatment of Graves' disease and the course of ophthalmopathy
Sridama, V., & DeGroot, L. J. (1989) · The American Journal of Medicine · doi:10.1016/s0002-9343(89)80485-1 · Cited by 137
Association between Graves' ophthalmopathy and smoking
Shine, B. S. F., Fells, P., Edwards, O. M., & Weetman, A. P. (1990) · The Lancet · doi:10.1016/0140-6736(90)91315-2 · Cited by 137
Smith, T. J., Bahn, R. S., Gorman, C. A., et al. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-5-1169 · Cited by 136
McIver, B., Rae, P., Beckett, G. J., Wilkinson, E., Gold, A., & Toft, A. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340403 · Cited by 135
Metcalfe, R. A., & Weetman, A. P. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02445.x · Cited by 134
Thyrotropin Receptor Transcripts in Human Adipose Tissue
Crisp, M., Lane, C., Halliwell, M., Wynford‐Thomas, D., & Ludgate, M. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.2003 · Cited by 134
Ericsson, U.-B. C., & Lindgärde, F. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00308.x · Cited by 132
Christensen, S. B., Ericsson, U.-B. C., Janzon, L., Tibblin, S., & Melander, A. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-4-615 · Cited by 130
Cloning and Functional Expression of a Thyrotropin Receptor cDNA from Rat Fat Cells
Endo, T., Ohta, K., Haraguchi, K., & Onaya, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10833 · Cited by 126
Marcocci, C., Bartalena, L., Panicucci, M., Marconcini, C., Cartei, F., Cavallacci, G., Laddaga, M., Campobasso, G., Baschieri, L., & Pinchera, A. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb00836.x · Cited by 119
Self-citationMarcocci, Bruno‐Bossio, Manetti, Tanda, M. L., Miccoli°, Iacconi, Bartolomei, Nardi, Pinchera, & Bartalena (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00843.x · Cited by 118
Cigarette smoking and the thyroid
Bartalena, L., Bogazzi, F., Tanda, M. L., Manetti, L., Dell'Unto, E., & Martino, E. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1330507 · Cited by 115
Self-citationOrbital Radiotherapy for Graves' Ophthalmopathy
Bartalena, L., Marcocci, C., Tanda, M. L., Rocchi, R., Mazzi, B., Barbesino, G., & Pinchera, A. (2002) · Thyroid · doi:10.1089/105072502753600223 · Cited by 115
Self-citationCYCLOSPORIN IMPROVES GRAVES' OPHTHALMOPATHY
Weetman, A. P., Ludgate, M. E., Mills, P. V., et al. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90514-7 · Cited by 114
Pinchera, A., Liberti, P., Martino, E., Fenzi, G., Grasso, L., Rovis, L., Baschieri, L., & Doria, G. (1969) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-29-2-231 · Cited by 110
Self-citationSmith, T. J., Bahn, R. S., & Gorman, C. A. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-5-1019 · Cited by 110
Randomized trial of intravenous immunoglobulins versus prednisolone in Graves' ophthalmopathy
Kahaly, G. J., Pitz, S., Müller‐Forell, W., & Hommel, G. (1996) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-854.x · Cited by 108
Weetman, A. P., & Wiersinga, W. M. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00487.x · Cited by 107
Cuddihy, R. M., Dutton, C. M., & Bahn, R. S. (1995) · Thyroid · doi:10.1089/thy.1995.5.89 · Cited by 105
Drevlow, B. E., Lovis, R. M., Haag, M. A., Sinacore, J. M., Jacobs, C. A., Blosche, C., LANDAY, A. L., Moreland, L. W., & Pope, R. M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390212 · Cited by 103
Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts.
Jm, K., Loftus, S. J., & Bahn, R. S. (1992) · PubMed · Cited by 99
McLachlan, S. M., Prummel, M. F., & Rapoport, B. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.5.8175962 · Cited by 98
Graves, P. N., Tomer, Y., & Davies, T. F. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91315-h · Cited by 93
Heufelder, A. E., Smith, T. J., Gorman, C. A., & Bahn, R. S. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-307 · Cited by 93
Treating severe Graves' ophthalmopathy
Bartalena, L., Marcocci, C., & Pinchera, A. (1997) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(97)80738-0 · Cited by 90
Self-citationNatural History of Thyroid Eye Disease
Perros, P., & Kendall‐Taylor, P. (1998) · Thyroid · doi:10.1089/thy.1998.8.423 · Cited by 89
Relationship Between Graves' Ophthalmopathy and Type of Treatment of Graves' Hyperthyroidism
Marcocci, C., Bartalena, L., Bogazzi, F., Bruno-Bossio, G., & Pinchera, A. (1992) · Thyroid · doi:10.1089/thy.1992.2.171 · Cited by 89
Self-citationCytokines in rheumatoid arthritis
Houssiau, F. (1995) · Clinical Rheumatology · doi:10.1007/bf02215851 · Cited by 89
The Effect of Somatostatin versus Corticosteroid in the Treatment of Graves' Ophthalmopathy
Kung, A. W. C., Michon, J., Tai, K. S., & Chan, F. L. (1996) · Thyroid · doi:10.1089/thy.1996.6.381 · Cited by 88
Paschke, R., Vassart, G., & Ludgate, M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02681.x · Cited by 87
Graves' Ophthalmopathy Following External Neck Irradiation for Nonthyroidal Neoplastic Disease
Wasnich, R. D., Grumet, F. C., Payne, R. C., & Kriss, J. P. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-5-703 · Cited by 87
Ala, Y., Palluy, O., Favero, J. J., Bonne, C., Modat, G., & Dornand, J. (1992) · Inflammation Research · doi:10.1007/bf01987902 · Cited by 86
Winsa, B., Rastad, J., Åkerström, G., Johansson, H., Westermark, K., & Karlsson, F. A. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320406 · Cited by 86
Analysis of orbital T cells in thyroid-associated ophthalmopathy
Förster, G. J., Otto, E., Hansen, C., Ochs, K., & Kahaly, G. J. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00613.x · Cited by 84
Octreotide‐scintigraphy is a disease‐activity parameter in Graves' ophthalmopathy
Gerding, M. N., van der Zant, F. M., van Royen, E. A., Koornneef, L., Krenning, E. P., Wiersinga, W. M., & Prummel, M. F. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00681.x · Cited by 84
Heufelder, A. E., & Bahn, R. S. (1994) · PubMed · Cited by 81
Prummel, M. F., Suttorp-Schulten, M. S. A., Wiersinga, W. M., Verbeek, A. M., Mourits, M. P., & Koornneef, L. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31607-6 · Cited by 81
Preventing Graves' Ophthalmopathy
Wiersinga, W. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380209 · Cited by 81
Bahn, R. S., Dutton, C. M., Heufelder, A. E., & Sarkar, G. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.2.7508946 · Cited by 79
Tan, G. H., Dutton, C. M., & Bahn, R. S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.2.8636247 · Cited by 79
TSH receptor gene expression in retroocular fibroblasts
Mengistu, M. E., Lukes, Y. G., Nagy, E. V., Burch, H. B., Carr, F. E., LAHIRI, S., & Burman, K. D. (1994) · Journal of Endocrinological Investigation · doi:10.1007/bf03347732 · Cited by 77
The Thyrotropin Receptor in Thyroid Eye Disease
Ludgate, M., Crisp, M., Lane, C., Costagliola, S., Vassart, G., Weetman, A. P., DAUNERIE, C., & Many, M. (1998) · Thyroid · doi:10.1089/thy.1998.8.411 · Cited by 77
STADLMAYR, W. (1997) · Thyroid · doi:10.1089/thy.1997.7.3 · Cited by 76
DONG, Q., Ludgate, M., & Vassart, G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-6-1375 · Cited by 76
Graves' disease, endocrine ophthalmopathy and smoking
Winsa, B., Mandahl, A., & Karlsson, F. A. (1993) · European Journal of Endocrinology · doi:10.1530/acta.0.1280156 · Cited by 75
Presence of nonfunctional thyrotropin receptor variant transcripts in retroocular and other tissues
Paschke, R., Metcalfe, A., Alcalde, L., Vassart, G., Weetman, A. P., & Ludgate, M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962314 · Cited by 75
High-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy
Antonelli, A., Saracino, A., ALBERTI, B., Canapicchi, R., Cartei, F., Lepri, A., Laddaga, M., & Baschieri, L. (1992) · European Journal of Endocrinology · doi:10.1530/acta.0.1260013 · Cited by 75
Moncayo, R., Baldissera, I., Decristoforo, C., Kendler, D. B., & Donnemiller, E. (1997) · Thyroid · doi:10.1089/thy.1997.7.21 · Cited by 74
Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO)
Pappa, A., Calder, V. L., Ajjan, R., Fells, P., Ludgate, M. E., Weetman, A. P., & Lightman, S. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.4491347.x · Cited by 74
Effect on Exophthalmos of Various Methods of Treatment of Graves' Disease
Gwinup, G. (1982) · JAMA · doi:10.1001/jama.1982.03320400047033 · Cited by 73
Intravenous Immunoglobulin versus Corticosteroid in Treatment of Graves' Ophthalmopathy
Baschieri, L., Antonelli, A., NARDI, S., ALBERTI, B., Lepri, A., Canapicchi, R., & Fallahi, P. (1997) · Thyroid · doi:10.1089/thy.1997.7.579 · Cited by 72
Otto, E. A., Ochs, K., Hansen, C., Wall, J. R., & Kahaly, G. J. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768872 · Cited by 71
Thyrotropin Receptor in Non-thyroid Tissues
Endo, T., Ohno, M., Kotani, S., Gunji, K., & Onaya, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1116 · Cited by 68
Mourits, M. P., Koornneef, L., Mourik-Noordenbos, A. M. V., van der Meulen-Schot, H. M., Prummel, M. F., Wiersinga, W. M., & Berghout, A. (1990) · British Journal of Ophthalmology · doi:10.1136/bjo.74.8.481 · Cited by 64
Radioiodine and the Immune System
DeGroot, L. J. (1997) · Thyroid · doi:10.1089/thy.1997.7.259 · Cited by 63
Kotsa, K., Watson, P. F., & Weetman, A. P. (1997) · Thyroid · doi:10.1089/thy.1997.7.31 · Cited by 63
Char, D. H. (1996) · British Journal of Ophthalmology · doi:10.1136/bjo.80.10.922 · Cited by 62
Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue
Spitzweg, C., Joba, W., Hunt, N., & Heufelder, A. E. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1360599 · Cited by 62
Medical Therapy of Graves' Disease: Does Thyroxine Prevent Recurrence of Hyperthyroidism?
Lucas, A., Salinas, I., Rius, F., Pizarro, E., Granada, M., Foz, M., & Sanmartı́, A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4118 · Cited by 61
Graves' Disease Occurring after Subacute Thyroiditis: Report of a Case and Review of the Literature
Bartalena, L., Bogazzi, F., PECORI, F., & Martino, E. (1996) · Thyroid · doi:10.1089/thy.1996.6.345 · Cited by 61
Self-citationAN EVALUATION OF PLASMA EXCHANGE FOR GRAVES' OPHTHALMOPATHY
Kelly, W. F., Longson, D., Smithard, D., Fawcitt, R., Wensley, R. T., Noble, J. L., & Keeley, J. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb02878.x · Cited by 57
Effects of smoking on thyroid function
Utiger, R. D. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380368 · Cited by 57
Clinical Presentation of Thyroid Associated Orbitopathy
Kendall‐Taylor, P., & Perros, P. (1998) · Thyroid · doi:10.1089/thy.1998.8.427 · Cited by 56
Graves' ophthalmopathy and tobacco smoking
Tallstedt, L., Lundell, G. E. F., & Taube, A. (1993) · European Journal of Endocrinology · doi:10.1530/acta.0.1290147 · Cited by 53
Tamai, H., Hayaki, I., Kawai, K., Komaki, G., Matsubayashi, S., Kuma, K., Kumagai, L. F., & Nagataki, S. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.5.7744989 · Cited by 52
URINARY GLYCOSAMINOGLYCANS IN Graves'OPHTHALMOPATHY*
Kahaly, G. J., Schüler, M., Sewell, A., Bernhard, G., Beyer, J., & Krause, U. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00463.x · Cited by 51
Surgery still has a role in Graves' hyperthyroidism.
Patwardhan, N. A., Moront, M. L., Rao, S. S., Rossi, S., & Braverman, L. E. (1993) · PubMed · Cited by 49
Radioiodine Treatment, Ablation, and Ophthalmopathy: A Balanced Perspective
Tallstedt, L., & Lundell, G. E. F. (1997) · Thyroid · doi:10.1089/thy.1997.7.241 · Cited by 48
Costagliola, S., Alcalde, L., Ruf, J., Vassart, G., & Ludgate, M. (1994) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0130011 · Cited by 48
SOMATOMEDIN C IN PATHOGENESIS OF MALIGNANT EXOPHTHALMOS OF ENDOCRINE ORIGIN
Hansson, H., Petruson, B., & Skottner, A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90698-7 · Cited by 48
Gunji, K., Bellis, A. D., Kubota, S., Swanson, J. K., Wengrowicz, S., Cochran, B. C., Ackrell, B. A. C., Salvi, M., Bellastella, A., Bizzarro, A., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5640 · Cited by 48
Comparison of RA 131I treatment protocols for Graves’ disease
DeGroot, L. J., Mangklabruks, A., & McCormick, M. (1990) · Journal of Endocrinological Investigation · doi:10.1007/bf03349519 · Cited by 47
The Treatment of Hyperthyroidism
Hershman, J. M. (1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-6-1306 · Cited by 46
Bohr, U. R. M., Behr, M., & Loos, U. (1993) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(93)90024-8 · Cited by 46
Therapeutic controversies. Radioiodine therapy does not aggravate Graves' ophthalmopathy.
Gorman, C. A. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.2.7852485 · Cited by 46
Watson, P. F., French, A., Pickerill, A. P., et al. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883818 · Cited by 43
Nakahara, H., Noguchi, S., Murakami, N., Morita, M. E., Tamaru, M., Ohnishi, T., Hoshi, H., Jinnouchi, S., Nagamachi, S., & Futami, S. (1995) · Radiology · doi:10.1148/radiology.196.3.7644656 · Cited by 43
Colao, A., Lastoria, S., Ferone, D., Pivonello, R., Macchia, P. E., Vassallo, P., Bonavolontà, G., Muto, P., Lombardi, G., & Fenzi, G. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.11.3790 · Cited by 43
Graves' ophthalmopathy after subtotal thyroidectomy and radioiodine therapy
Fernández Śnchez, J. R., Pradas, J. R., Martinez, O. C., Vela, E. T., Jimenez, F. E., Fuentes, I. G., & Thorbeck, R. V. (1993) · Journal of British Surgery · doi:10.1002/bjs.1800800921 · Cited by 40
Burch, H. B., Sellitti, D. F., Barnes, S. G., Nagy, E. V., Bahn, R. S., & Burman, K. D. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.8200941 · Cited by 39
Effects of Octreotide Treatment on Graves' Ophthalmopathy and Circulating sICAM-1 Levels
Özata, M., Bolu, E., Şengül, A., Taşar, M., Beyhan, Z., Çorakçı, A., & Gündoğan, M. A. (1996) · Thyroid · doi:10.1089/thy.1996.6.283 · Cited by 38
OPHTHALMOPATHY AND THYROID STIMULATION
Karlsson, F., Westermark, K., Dahlberg, P.-A., Jansson, R., & Enoksson, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90945-8 · Cited by 38
Effect of Subtotal Thyroidectomy on Natural History of Ophthalmopathy in Graves’ Disease
Abe, Y., Sato, H., Noguchi, M., Mimura, T., Sugino, K., Ozaki, O., Yoshimura, H., & Ito, K. (1998) · World Journal of Surgery · doi:10.1007/s002689900458 · Cited by 37
Somatostatin Analogues in the Treatment of Thyroid Eye Disease
Krassas, G. E. (1998) · Thyroid · doi:10.1089/thy.1998.8.443 · Cited by 35
Heufelder, A. E. (1997) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(97)80723-9 · Cited by 35
Hiromatsu, Y., Yang, D., Miyake, I., Koga, M., KAMEO, J., Sato, M., Inoue, Y., & Nonaka, K. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.1.4478 · Cited by 34
Treatment of Graves' disease by carbimazole: high dose with thyroxine compared to titration dose
Edmonds, C. J., & Tellez, M. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1310120 · Cited by 33
Has the target autoantigen for Graves' ophthalmopathy been found?
McGregor, A. M. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79573-8 · Cited by 33
The genetic susceptibility to Graves' disease
Tomer, Y., & Davies, T. F. (1997) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(97)80678-7 · Cited by 33
Rheumatoid Arthritis: Anticytokine Therapies on the Horizon
Koopman, W. J., & Moreland, L. W. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-3-199802010-00010 · Cited by 32
Takeshita, A., Nagayama, Y., Fujiyama, K., Yokoyama, N., Namba, H., Yamashita, S., Izumi, M., & Nagataki, S. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91360-3 · Cited by 32
The influence of surgery on endocrine ophthalmopathy
Frilling, A., Goretzki, P. E., Grußendorf, M., Erbslöh, M., & Röher, H.-D. (1990) · World Journal of Surgery · doi:10.1007/bf01658552 · Cited by 32
Guimarães, V. C., Quintáns, J., Fisfalen, M. E., Straus, F. H., Wilhelm, K., Medeiros-Neto, A., & DeGroot, L. J. (1995) · Endocrinology · doi:10.1210/endo.136.8.7543043 · Cited by 32
Long-term visual outcome following orbital decompression for dysthyroid eye disease
Hutchison, B. M., & Kyle, P. (1995) · Eye · doi:10.1038/eye.1995.143 · Cited by 31
Ablative or non-ablative therapy for Graves’ hyperthyroidism in patients with ophthalmopathy?
Marcocci, C., Bartalena, L., & Pinchera, A. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03347329 · Cited by 30
Self-citationPappa, A., Calder, V. L., Fells, P., & Lightman, S. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.3621258.x · Cited by 30
Long‐term effects of radioiodine on thyrotrophin receptor antibodies in Graves' disease
Alzawa, Y., Yoshida, K., KAISE, N., KAISE, K., Fukazawa, H., KISO, Y., Mori, K., SAYAMA, N., KIKUCHI, K., & Abe, K. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02671.x · Cited by 30
DE, G. M. A. D. (1967) · The Lancet · doi:10.1016/s0140-6736(67)92019-3 · Cited by 28
Evaluation of thyroid ablative therapy for ophthalmopathy of Graves' disease
DeGroot, L. J., & Benjasuratwong, Y. (1996) · Orbit · doi:10.3109/01676839609150236 · Cited by 27
Biological therapies: A novel approach to the treatment of autoimmune disease
Fox, D. A. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80109-0 · Cited by 26
Plasma glycosaminoglycans in endocrine ophthalmopathy
Kahaly, G. J., Hansen, C., Beyer, J., & WINAND, R. J. (1994) · Journal of Endocrinological Investigation · doi:10.1007/bf03344962 · Cited by 26
Acetylcholinesterase antibodies and thyroid autoimmunity.
Weetman, A. P., Tse, C. K., Randall, W. R., Tsim, K. W. K., & Barnard, E. A. (1988) · PubMed Central · Cited by 25
Therapeutic controversies. Retrobulbar radiation in Graves' ophthalmopathy.
Wiersinga, W. M., & Prummel, M. F. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.2.7852487 · Cited by 25
Mühlberg, T., Heberling, H. J., Joba, W., et al. (1997) · PubMed · Cited by 24
Immunosuppressant therapy of thyroid eye disease
Kahaly, G. J., & Beyer, J. (1988) · Journal of Molecular Medicine · doi:10.1007/bf01711917 · Cited by 23
Zhang, Z.-G., Wall, J. R., & Bernard, N. F. (1996) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.0119 · Cited by 20
Immunomodulatory Treatment of Graves' Ophthalmopathy
Prummel, M. F., & Wiersinga, W. M. (1998) · Thyroid · doi:10.1089/thy.1998.8.545 · Cited by 20
TSH suppression combined with carbimazole for Graves' disease: effect on remission and relapse rates
Pujol, P., Osman, A., Grabar, S., Daurès, J., Galtier, F., Boegner, C., Baldet, L., Raye, R., Bringer, J., & Jaffiol, C. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00466.x · Cited by 15
Immunosuppressive treatment of Graves' ophthalmopathy
Wiersinga, W. M. (1990) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(90)90095-k · Cited by 14
Plasma exchange in endocrine ophthalmopathy
Berlin, G., Hjelm, H., Liedén, G., & Tegler, L. (1990) · Journal of Clinical Apheresis · doi:10.1002/jca.2920050405 · Cited by 13
Mori, S., YOSHIKAWA, N., Tokoro, T., Ikehara, S., Inoue, Y., Nishikawa, M., & Inada, M. (1996) · Thyroid · doi:10.1089/thy.1996.6.275 · Cited by 12
Ablative or non-ablative therapy for Graves’ hyperthyroidism in patients with ophthalmopathy?
Weetman, A. P., & Harrison, B. J. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03347330 · Cited by 12
Is Graves Ophthalmopathy a Preventable Disease?
Keltner, J. L. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.8.1106 · Cited by 11
[Effect of the treatment of hyperthyroidism on the course of exophthalmos].
Chávez, C. V., Nishimura Meguro, E., Said, L. E., Delgado Falfari, A., & de Viteri, M. S. (1992) · PubMed · Cited by 11
Therapy for Hyperthyroidism and Graves' Ophthalmopathy
Gorman, C. A., & Offord, K. P. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382114 · Cited by 10
Current management of thyroid‐associated ophthalmopathy
Kendall‐Taylor, P. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00563.x · Cited by 9
Radioiodine and thyroid-associated ophthalmopathy
Marcocci, C., Bartalena, L., Bogazzi, F., Bruno-Bossio, G., Tanda, M. L., Manetti, L., Dell'Unto, E., & Pinchera, A. (1996) · Orbit · doi:10.3109/01676839609150237 · Cited by 6
Self-citationColzani, R., Alex, S., Dunn, A. D., Dunn, J. T., Stone, S., & Braverman, L. E. (1999) · Thyroid · doi:10.1089/thy.1999.9.831 · Cited by 5
Cited by
Bahn, R. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0905750 · Cited by 1,552
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
Bartalena, L., Baldeschi, L., Dickinson, A., Eckstein, A., Kendall-Taylor, P., Marcocci, C., Mourits, M., Perros, P., Boboridis, K., Boschi, A., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0666 · Cited by 795
Self-citationSelenium and the Course of Mild Graves' Orbitopathy
Marcocci, C., Kahaly, G. J., Krassas, G. E., Bartalena, L., Prummel, M., Stahl, M., Altea, M. A., Nardi, M., Pitz, S., Boboridis, K., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012985 · Cited by 619
Self-citationEpidemiology and Prevention of Graves' Ophthalmopathy
Wiersinga, W. M., & Bartalena, L. (2002) · Thyroid · doi:10.1089/105072502761016476 · Cited by 458
Self-citationRandomized, Single Blind Trial of Intravenous versus Oral Steroid Monotherapy in Graves’ Orbitopathy
Kahaly, G. J., Pitz, S., Hommel, G., & Dittmar, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0148 · Cited by 423
Metadata
- Authors
- Bartalena, L., Pinchera, A., & Marcocci, C.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2000-04-01
- Volume
- 21
- Issue
- 2
- Pages
- 168-199
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2133188970
- Cited by
- 677
- References
- 176
- FWCI
- 16.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.